2nd Edition of International Cancer & Immuno-Oncology Conference
March 19-21, 2026 | Singapore
Urinary Bladder Cancer
Urinary bladder cancer poses significant challenges in diagnosis and treatment due to its diverse subtypes and varying degrees of aggressiveness. Researchers are delving into innovative approaches to tackle this disease. From advanced imaging techniques like MRI and PET scans for precise tumor mapping to the development of targeted therapies aimed at specific genetic mutations driving cancer growth, the landscape of bladder cancer research is evolving rapidly. Immunotherapy, particularly checkpoint inhibitors, has emerged as a promising avenue, harnessing the body's immune system to fight cancer cells. Moreover, ongoing studies are exploring the role of lifestyle factors, environmental exposures, and genetic predispositions in bladder cancer development, paving the way for personalized prevention and treatment strategies. Collaborative efforts between scientists, clinicians, and patients are crucial in driving forward breakthroughs in understanding, diagnosing, and treating urinary bladder cancer effectively.
Rajvir Dahiya
University of California San Francisco, United States
Atif A Ahmed
University of Washington-Seattle Children’s Hospital, United States
Anyou Wang
DIFIBER LLC, United States
Paulo Cesar De Morais
Catholic University of Brasilia, Brazil
Allen Chen
Olympic Medical Center, United States
Shilpa S Dhar
UT MD Anderson Cancer Center, United States
Ritu Khanna
University of Manchester, United KingdomSubmit your abstract Today
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : tRNA-derived fragment 3′tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer
Feng Yan, The Affiliated Cancer Hospital of Nanjing Medical University, China
Title : Integrating single-cell and spatial transcriptomics to uncover and elucidate GP73-mediated pro-angiogenic regulatory networks in hepatocellular carcinoma
Jiazhou Ye, Guangxi Medical University Cancer Hospital, China
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Analysis of the dynamic evolution and influencing factors of nutritional risk in breast cancer patients during treatment
Jingwen Yan, Sun Yat-sen University, China
Title : Integrative multi-omics reveals metabolic–stemness coupling and novel therapeutic targets in osteosarcoma chemoresistance
Jinyan Feng, Tianjin Medical University Cancer Institute and Hospital, China